Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathis Grossmann

Showing results (91-100 of 189) with videos related to

Pageof 19
Sort By:
Clinical Endocrinology|December 18, 2019
Australian endocrinologists need more training in transgender health: A national surveyIngrid Bretherton, Mathis Grossmann, Shalem Y Leemaqz, et al.
Internal Medicine Journal|January 11, 2018
Diagnosis and management of hyponatraemia in the older patientMichael Woodward, Peter Gonski, Mathis Grossmann, et al.
Pathology|November 21, 2021
Multicentric EBV-associated smooth muscle tumour with involvement of the pituitary glandStephanie Lau, Jasmine Zhu, Alanna Tan, et al.
World Journal of Hepatology|June 1, 2022
Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrationsRoss Apostolov, Emily Gianatti, Darren Wong, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 2025
Response to Letter to the Editor From Sumi and Tominaga: "Tolvaptan vs Fluid Restriction in Moderate-Profound Hyponatremia: An Open-Label Randomized Clinical Trial"Annabelle M Warren, Mathis Grossmann, Rudolf Hoermann, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|October 5, 2022
Bone health assessment with dual energy X-ray absorptiometry in men with high-risk prostate carcinoma commencing adjuvant androgen deprivation therapyBelinda Pan, Noel J Aherne, Thomas P Shakespeare, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2025
Tolvaptan versus fluid restriction in moderate-profound hyponatremia: An open-label randomized clinical trialAnnabelle M Warren, Mathis Grossmann, Rudolf Hoermann, et al.
Clinical Endocrinology|June 30, 2015
Effect of testosterone treatment on cardiac biomarkers in a randomized controlled trial of men with type 2 diabetesEmily J Gianatti, Rudolf Hoermann, Que Lam, et al.
International Journal of Obesity (2005)|January 10, 2019
A body shape index (ABSI) reflects body composition changes in response to testosterone treatment in obese menRudolf Hoermann, Mark Ng Tang Fui, Jesse C Krakauer, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 20, 2016
Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease scoreMarie Sinclair, Paul J Gow, Mathis Grossmann, et al.
Pageof 19

Showing results (91-100 of 189) with videos related to

Sort By:
Pageof 19
Clinical Endocrinology|December 18, 2019
Australian endocrinologists need more training in transgender health: A national surveyIngrid Bretherton, Mathis Grossmann, Shalem Y Leemaqz, et al.
Internal Medicine Journal|January 11, 2018
Diagnosis and management of hyponatraemia in the older patientMichael Woodward, Peter Gonski, Mathis Grossmann, et al.
Pathology|November 21, 2021
Multicentric EBV-associated smooth muscle tumour with involvement of the pituitary glandStephanie Lau, Jasmine Zhu, Alanna Tan, et al.
World Journal of Hepatology|June 1, 2022
Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrationsRoss Apostolov, Emily Gianatti, Darren Wong, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 2025
Response to Letter to the Editor From Sumi and Tominaga: "Tolvaptan vs Fluid Restriction in Moderate-Profound Hyponatremia: An Open-Label Randomized Clinical Trial"Annabelle M Warren, Mathis Grossmann, Rudolf Hoermann, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|October 5, 2022
Bone health assessment with dual energy X-ray absorptiometry in men with high-risk prostate carcinoma commencing adjuvant androgen deprivation therapyBelinda Pan, Noel J Aherne, Thomas P Shakespeare, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2025
Tolvaptan versus fluid restriction in moderate-profound hyponatremia: An open-label randomized clinical trialAnnabelle M Warren, Mathis Grossmann, Rudolf Hoermann, et al.
Clinical Endocrinology|June 30, 2015
Effect of testosterone treatment on cardiac biomarkers in a randomized controlled trial of men with type 2 diabetesEmily J Gianatti, Rudolf Hoermann, Que Lam, et al.
International Journal of Obesity (2005)|January 10, 2019
A body shape index (ABSI) reflects body composition changes in response to testosterone treatment in obese menRudolf Hoermann, Mark Ng Tang Fui, Jesse C Krakauer, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 20, 2016
Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease scoreMarie Sinclair, Paul J Gow, Mathis Grossmann, et al.
Pageof 19